Belvedere Trading
HGEN

Belvedere Trading’s HUMANIGEN, INC. HGEN Stock Holding History

Belvedere Trading’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,347
Closed -$145K – 625
2022
Q1 		$145K Buy
+63,347
New +$170K ﹤0.01% 276
2021
Q3 		– Sell
-41,548
Closed -$584K – 641
2021
Q2 		$710K Buy
41,548
+19,162
+86% +$349K 0.05% 78
2021
Q1 		$428K Buy
+22,386
New +$409K 0.04% 102

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's HGEN Position: Q2 2022 in Review

Belvedere Trading sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 63,347 shares — an estimated $145K sold.

Belvedere Trading first reported a position in HGEN in Q1 2021 and held it in 3 quarters. The position peaked at $710K in Q2 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Belvedere Trading reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 63,347 HUMANIGEN, INC. shares in Q2 2022, an estimated $145K.
  • Belvedere Trading first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 3 quarters.
  • Belvedere Trading's HUMANIGEN, INC. position peaked at $710K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.